USPTO grants University of California 20th CRISPR patent
02-01-2020
CRISPR: A licence to heal
01-10-2019
USPTO revives fight over CRISPR patents
27-06-2019
panuwach / Shutterstock.com
The US Patent and Trademark Office (USPTO) has granted a new CRISPR-Cas9 patent to the University of California (UC), the University of Vienna and Emmanuelle Charpentier, marking the fifth consecutive week that the USPTO has approved a new patent in their CRISPR portfolio.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
US Patent and Trademark Office, CRISPR-Cas9, University of California, gene-editing, University of Vienna, Emmanuelle Charpentier
